View in EDS

Real-World Outcomes of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Obese Patients With Ulcerative Colitis and IPAA With a History of Pouchitis.

Saved in:

Bibliographic Details
Title:	Real-World Outcomes of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Obese Patients With Ulcerative Colitis and IPAA With a History of Pouchitis.
Authors:	Desai A; Division of Gastroenterology, Hepatology & Nutrition, Allegheny Health Network, Pittsburgh, PA, United States., Habib H; Department of Medicine, Medicine Institute, Allegheny Health Network, Pittsburgh, PA, United States., Khataniar H; Department of Medicine, Medicine Institute, Allegheny Health Network, Pittsburgh, PA, United States., Farraye FA; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States., Sehgal P; Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA, United States., Barnes EL; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Kochhar GS; Division of Gastroenterology, Hepatology & Nutrition, Allegheny Health Network, Pittsburgh, PA, United States., Hashash JG; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States.
Source:	Inflammatory bowel diseases [Inflamm Bowel Dis] 2026 May 01; Vol. 32 (5), pp. 869-874.
Publication Type:	Journal Article
Journal Info:	Publisher: Oxford University Press Country of Publication: England NLM ID: 9508162 Publication Model: Print Cited Medium: Internet ISSN: 1536-4844 (Electronic) Linking ISSN: 10780998 NLM ISO Abbreviation: Inflamm Bowel Dis Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1536-4844
DOI:	10.1093/ibd/izaf301